BioSpace News Archive

Onc.AI today announced that new data will be presented at the 2024 Annual Society of Clinical Oncology (ASCO) resulting from its collaboration with Pfizer.

Aurinia Pharmaceuticals Inc. announced that it will attend the 2024 Jefferies Global Healthcare Conference in New York from June 4-6, 2024.

Chimerix announced that Mike Andriole, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 3:00 p.m. ET.

Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd., today announced the landmark overall survival (OS) analysis of camrelizumab and rivoceranib as a first-line treatment for unresectable hepatocellular carcinoma (uHCC) will be presented at an in-person poster presentation during the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting on June 1.

Axsome Therapeutics, Inc., a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, announced that Axsome will participate in two upcoming investor conferences.

Gain Therapeutics, Inc. announced that a late-breaking abstract with new data on GT-02287 has been accepted for presentation at FENS Forum 2024 being held June 25-29, 2024 in Vienna, Austria.

Tiziana Life Sciences, Ltd. announced that Howard L. Weiner, M.D., Chairman of Tiziana’s Scientific Advisory Board and co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, a founding member of Mass General Brigham healthcare system, is being honored with the prestigious “Giants of MS” award for his outstanding contributions in the area of multiple sclerosis research.

Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update.

Precision BioSciences, Inc. today announced that members of management will participate in the following upcoming investor conferences in June.

OneOncology, the fastest growing platform for independent oncology practices, is pleased to highlight the groundbreaking research efforts of investigators at OneOncology partner practices through 13 oral and poster presentations at the 2024 ASCO Annual Meeting May 31-June 4, 2024.